`-Please file with BG12 MS IND.
`
`26-Jul-2005 03:13 PM
`
`Message Size: 6.9 KB
`
`cc
`
`bee
`
`Subject Fw: PIND 73,061 BG00012 Meeting Request
`
`"Wheeloua, T ereaa A •
`<WHEELOUST@cder .fda.gov
`>
`07/26/2005 03:09PM
`
`To
`
`cc
`
`Subject PIND 73,061 BG00012 Meeting Request
`
`• Please refer to your conespondence dated July 8, 2005 and received July 11, 2005, requesting a
`
`type B Pre-IND meeting.
`
`Based on the statement of purpose, objectives, and proposed agenda, we consider the meeting a
`type B meeting as described in our guidance for indusiiy titled Formal Meetings with Sponsors
`and Applicants for PDUFA Products (Febmary 2000). The meeting is scheduled for:
`
`Date: September 1, 2005
`Time: 2 PM - 3 PM
`Location: 1451 Rockville Pike, Conference RoomE, Rockville, :tvm 20852
`CDER participants: To be detennined
`
`Please have all attendees bring photo identification and allow 15-30 minutes to complete security
`clearance. If there are additional attendees, email that infonnation to me at
`wheeloust@cder.fda.gov so that I can give the security staff time to prepare temponuy badges in
`advance. Upon anival at FDA, give the guards either of the following munbers to request an
`escort to the conference room: Teresa Wheelous or the division secretaty at 301-594-2850.
`
`Additionally, please email your discussion questions to me in MS WORD f01mat.
`
`Provide the backgrmmd inf01mation for this meeting (one copy to the IND and 9 desk c.opies to
`me) at least one month prior to the meeting. If the materials presented in the inf01mation
`package are inadequate to justify holding a meeting, or if we do not receive the package by
`
`Page 1 of2
`
`Biogeo Exhibit 2291
`Coalition v. Biogeo
`IPR2015-01993
`
`
`
`August 2, 2005, we may cancel or reschedule the meeting.
`
`CDR Teresa Wheelous, R. Ph.
`Senior Regulatory Management Officer
`Office of Drug Evaluation I
`Division of Neurology Products
`HFD-120
`1451 Rockville Pike
`Rockville, MD 20852
`Telephone (301) 594-5504
`Fax (301) 594-2859
`
`Page 2 of 2